samedan logo

 
 
spacer
home > pmps > winter 2021 > pmps and flypharma webinar: what we learned
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

PMPS and FlyPharma Webinar: What We Learned

Mike Alkire at Premier Inc

The January 19th webinar, Challenges and Opportunities for Pharma Manufacturing and Logistics in the Face of COVID-19, sparked a meaningful discussion about the obstacles that pharmaceutical suppliers experienced in 2020 amidst the pandemic.

During the webinar, panellists discussed vaccine distribution and challenges in meeting the demand. The panellists noted that 2020 was an extremely difficult year for everyone – especially for manufacturers. They noted that their key focus in 2020 was to manage supplier risk and manufacture medications to reach patients in a timely manner. They also focused on managing risk within their manufacturing operations, making sure they could continue to meet their quality and safety standards.

As we know, suppliers unexpectedly experienced a huge demand in supplies in a very short amount of time. The onset of the pandemic was a challenging situation for any company – no one was really prepared for it – so it was very complex to quickly move products from different sources.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.


spacer
Luiz Barberini at Bayer

MBA, mechanical engineer, CQE and APICS CSCP and CPIM certified, with three post-graduate degrees in Marketing, Logistics and Transport, Luiz has worked for almost 30 years in activities related to supply chain, procurement, and logistics. He has also coordinated the dangerous goods ’transport’ committee at the Brazilian Chemical Industry Association (ABIQUIM).

Luiz currently works as Operations Manager for Latin America External Manufacturing Operations Consumer Health at Bayer and teaches Negotiation, Supply Chain and Demand Management for some major post-graduate schools in São Paulo. He also coordinates postgraduate courses in two universities in Brazil.

Michael J Alkire at Premier Inc

Michael is President of Premier, one of the largest global supply chain, healthcare technology companies in the US, helping hospitals and health systems provide higher quality patient care at a better cost. From leading the integration of Premier’s clinical, financial, supply chain to driving its operational performance offerings, Michael also oversees the company’s quality, safety, labour, and supply chain technology solutions.

Yulia Celetaria at Volga-Dnepr Group

Yulia is an industry expert with over 15 years of experience in the air cargo sector and pharmaceutical logistics. She started her career in 2005 as part of the Customer Service team of AirBridgeCargo Airlines, based in Moscow. She has recently been promoted to Healthcare Director of Volga-Dnepr Group and will be responsible for the healthcare and humanitarian sector.

Ada Palmadottir at Controlant

Ada is Business Development Director at Controlant. With more than 20 years of experience in pharmacy, management, and technology, Ada has extensive international experience in sales, operations, and marketing, specifically in the areas of product, vertical alliance sales, and partnerships related to pharmaceutical products. She is a licensed and experienced pharmacist and earned a Master of Pharmacy from the University of Iceland and a Master of Business Administration from the Norwegian School of Management in Oslo. Ada has been working with Controlant for the last nine years.

Stephen Meredith at Ipsen

Stephen was appointed at Ipsen as Director, Manufacturing in March 2020 and is currently acting Vice President, Tech Ops.

Stephen is an experienced Director with a demonstrated history of driving improved performance in the pharmaceutical, biotechnology, and speciality chemicals industries. Skilled in operational management, supply chain, contract management, acquisition integration, new product introduction, engineering, and external manufacturing, he has demonstrated cross-functional leadership across borders and cultures, with strong leadership expertise, business acumen and the ability to build a winning team.

Mario Patyk at Leipzig/Halle Airport

Although Mario was born in Leipzig, it did take him a while to realise that the city actually had a cargo airport. Certainly, at the beginning of his career at Frankfurt Airport many moons ago, no one expected Leipzig/ Halle Airport, where he is now Head of Business Development, to play any significant role in air freight.

So, one can imagine the surprised look on Mario’s face, when the largest cargo carrier in Europe – DHL – announced their move to Leipzig/ Halle Airport in 2004.
spacer
Luiz Barberini
spacer
spacer
spacer
Michael Alkire
spacer
spacer
spacer
Yulia Celetaria
spacer
spacer
spacer
Ada Palmadottir
spacer
spacer
spacer
Stephen Meredith
spacer
spacer
spacer
Mario Patyk
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

New laboratory and regulatory services for biotech customers

USA/Germany, September 21, 2020. Gerresheimer adds essential laboratory and regulatory services to its broad portfolio of products, solutions and services for biotech companies. Specialized laboratory technicians and an experienced team of further specialists offer these services in the two innovation and technology centers in Bünde (Germany) and Vineland (New Jersey/USA). Gx Biological Solutions offers full service for biotech companies regarding product development of primary packaging and drug delivery solutions, material and functional testing as well as comprehensive regulatory support. The partnership with Gerresheimer shortens the time to market for pharmaceutical companies, minimizes risks and saves resources.
More info >>

White Papers

Points to Consider When Developing a TMF (Trial Master File) Strategy

Phlexglobal Ltd

Many organizations are currently outsourcing clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing throughout the conduct of a clinical trial. Outsourcing minimizes the costs of recruiting experts, building a team and maintaining an infrastructure. However, it can also add complexity as the organization looks to meets its compliance obligations regarding clinical trial documentation. The documentation referred to in Article 15(5) of Directive 2001/20/EC as the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.1 This essential study specific documentation is also known as the TMF. As organizations try to minimize their reliance on paper files, the electronic TMF (eTMF) has emerged. A current industry initiative to standardize the organization of this content is known as the TMF Reference Model. This model is helping standardization efforts across paper and electronic systems. As companies implement outsourcing strategies, CROs and sponsor organizations look for a common foundation on which to build their TMF capabilities. The following paper outlines some of the challenges organizations face when outsourcing clinical trial activities to multiple contract research organizations and a strategy to facilitate partnering and management of trial information between sponsors and CROs.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement